Michael Duerr

848 total citations
32 papers, 470 citations indexed

About

Michael Duerr is a scholar working on Transplantation, Nephrology and Hepatology. According to data from OpenAlex, Michael Duerr has authored 32 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Transplantation, 11 papers in Nephrology and 7 papers in Hepatology. Recurrent topics in Michael Duerr's work include Renal Transplantation Outcomes and Treatments (24 papers), Renal Diseases and Glomerulopathies (9 papers) and Organ Donation and Transplantation (5 papers). Michael Duerr is often cited by papers focused on Renal Transplantation Outcomes and Treatments (24 papers), Renal Diseases and Glomerulopathies (9 papers) and Organ Donation and Transplantation (5 papers). Michael Duerr collaborates with scholars based in Germany, Switzerland and Canada. Michael Duerr's co-authors include Klemens Budde, Fabian Halleck, Johannes Waiser, Eva Schrezenmeier, Nils Lachmann, Lutz Liefeldt, Lukas Lehner, Oliver Staeck, Petra Glander and Dmytro Khadzhynov and has published in prestigious journals such as Journal of the American Society of Nephrology, Transplantation and American Journal of Transplantation.

In The Last Decade

Michael Duerr

31 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Duerr Germany 12 293 147 118 80 61 32 470
Varsha B. Trivedi India 11 243 0.8× 146 1.0× 83 0.7× 24 0.3× 43 0.7× 26 419
Attapong Vongwiwatana Thailand 9 303 1.0× 197 1.3× 88 0.7× 102 1.3× 141 2.3× 35 665
Supreet Sethi United States 14 397 1.4× 255 1.7× 98 0.8× 49 0.6× 26 0.4× 24 559
J. Strehlau Germany 14 295 1.0× 171 1.2× 98 0.8× 61 0.8× 48 0.8× 28 565
Andrew Bentall United States 14 491 1.7× 285 1.9× 115 1.0× 76 0.9× 56 0.9× 51 693
Matthew J. Vitalone United States 14 512 1.7× 350 2.4× 87 0.7× 100 1.3× 105 1.7× 16 670
A. McLean United Kingdom 10 318 1.1× 139 0.9× 68 0.6× 102 1.3× 34 0.6× 16 508
George Wadih United States 9 299 1.0× 285 1.9× 30 0.3× 75 0.9× 50 0.8× 11 555
Marta Myszka Poland 11 285 1.0× 233 1.6× 44 0.4× 42 0.5× 33 0.5× 24 479
Marcelina Żabińska Poland 13 296 1.0× 228 1.6× 32 0.3× 59 0.7× 41 0.7× 40 569

Countries citing papers authored by Michael Duerr

Since Specialization
Citations

This map shows the geographic impact of Michael Duerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Duerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Duerr more than expected).

Fields of papers citing papers by Michael Duerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Duerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Duerr. The network helps show where Michael Duerr may publish in the future.

Co-authorship network of co-authors of Michael Duerr

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Duerr. A scholar is included among the top collaborators of Michael Duerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Duerr. Michael Duerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duerr, Michael, Fabian Halleck, Lutz Liefeldt, et al.. (2025). Impact of Hepatitis B Infection on Patient and Graft Survival After Kidney Transplantation. Journal of Clinical Medicine. 14(6). 2124–2124.
2.
Metzke, Diana, Jan Klocke, Michael Duerr, et al.. (2022). Urinary CD8+HLA-DR+ T Cell Abundance Non-invasively Predicts Kidney Transplant Rejection. Frontiers in Medicine. 9. 928516–928516. 3 indexed citations
3.
Zhang, Qiang, Klemens Budde, Danilo Schmidt, et al.. (2021). Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy. Frontiers in Medicine. 8. 666319–666319. 1 indexed citations
4.
Zhang, Qiang, Birgit Rudolph, Mira Choi, et al.. (2020). The relationship between proteinuria and allograft survival in patients with transplant glomerulopathy: a retrospective single‐center cohort study. Transplant International. 34(2). 259–271. 3 indexed citations
5.
Duerr, Michael, Lutz Liefeldt, Frank Friedersdorff, et al.. (2020). Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients. Journal of Clinical Medicine. 10(1). 89–89. 6 indexed citations
6.
Choi, Mira, Friederike Bachmann, Marcel G. Naik, et al.. (2020). Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center. Journal of Clinical Medicine. 9(11). 3401–3401. 11 indexed citations
7.
Lehner, Lukas, Nils Lachmann, Robert W. Peters, et al.. (2020). Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified Lymphoceles. Journal of Clinical Medicine. 9(9). 2841–2841. 8 indexed citations
8.
Khadzhynov, Dmytro, Lukas Lehner, Michael Duerr, et al.. (2020). Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients. Transplant Immunology. 63. 101333–101333. 4 indexed citations
9.
Duerr, Michael, Eva Schrezenmeier, Lukas Lehner, et al.. (2019). A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients. BMC Nephrology. 20(1). 36–36. 7 indexed citations
10.
Waiser, Johannes, Jens Klotsche, Nils Lachmann, et al.. (2019). Predictors of graft survival at diagnosis of antibody‐mediated renal allograft rejection: a retrospective single‐center cohort study. Transplant International. 33(2). 149–160. 7 indexed citations
11.
Augustine, Titus, John S. Gill, Klemens Budde, et al.. (2019). INTERNATIONAL, MATCHED-COHORT CHECKERBOARD STUDY OF QUALITY OF LIFE AND DISEASE BURDEN IN KIDNEY TRANSPLANT (TX) PATIENTS WITH ANTIBODY-MEDIATED REJECTION (AMR). Transplant International. 32. 310–310. 1 indexed citations
12.
Halleck, Fabian, Dmytro Khadzhynov, Lukas Lehner, et al.. (2018). Impact of Pre-existing Comorbidities on Long-term Outcomes in Kidney Transplant Recipients. Transplantation Proceedings. 50(10). 3232–3241. 15 indexed citations
13.
Budde, Klemens, Martin Zeier, Oliver Witzke, et al.. (2017). Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial. Nephrology Dialysis Transplantation. 32(6). 1060–1070. 29 indexed citations
14.
Schrezenmeier, Eva, Klemens Budde, Oliver Staeck, et al.. (2017). Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in Germany. Transplantation Proceedings. 49(10). 2269–2273. 7 indexed citations
15.
Halleck, Fabian, Dmytro Khadzhynov, Lutz Liefeldt, et al.. (2016). Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?. Nephrology Dialysis Transplantation. 31(12). 2143–2149. 22 indexed citations
16.
Waiser, Johannes, Michael Duerr, Klemens Budde, et al.. (2016). Treatment of Acute Antibody-Mediated Renal Allograft Rejection With Cyclophosphamide. Transplantation. 101(10). 2545–2552. 15 indexed citations
17.
Waiser, Johannes, Michael Duerr, Constanze Schönemann, et al.. (2016). Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection. Transplantation Direct. 2(8). e91–e91. 9 indexed citations
18.
Lin, Chenfang, Yexin Feng, Michael Duerr, et al.. (2014). Direct observation of ordered configurations of hydrogen adatoms on graphene. arXiv (Cornell University). 2015. 1 indexed citations
19.
Halleck, Fabian, Michael Duerr, Johannes Waiser, et al.. (2012). An evaluation of sirolimus in renal transplantation. Expert Opinion on Drug Metabolism & Toxicology. 8(10). 1337–1356. 24 indexed citations
20.
Duerr, Michael, et al.. (2010). Increased Incidence of Angioedema with ACE Inhibitors in Combination with mTOR Inhibitors in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology. 5(4). 703–708. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Varsha B. Trivedi Breakdown of academic impact, for papers by Attapong Vongwiwatana Breakdown of academic impact, for papers by Supreet Sethi Breakdown of academic impact, for papers by J. Strehlau Breakdown of academic impact, for papers by Andrew Bentall Breakdown of academic impact, for papers by Matthew J. Vitalone Breakdown of academic impact, for papers by A. McLean Breakdown of academic impact, for papers by George Wadih Breakdown of academic impact, for papers by Marta Myszka Breakdown of academic impact, for papers by Marcelina Żabińska
Rankless by CCL
2026